Press Releases
I. Commencement of next phase of India's nationwide Covid-19 vaccination drive
Starting 1st March, people aged more than 60 years and those who are 45 plus and have co-morbidities will be able to get a vaccine against Covid-19 at a government centre or a private hospital. The vaccination will be carried out at more than 10,000 government centres and over 20,000 private vaccination centres across the country. This is part of the next phase of India's nationwide Covid-19 vaccination that started on January 16. In the first phase of the vaccination drive, healthcare workers on Covid-19 duty were vaccinated. The second phase covered other frontline workers and people engaged in essential services.
II. Cabinet approves Production Linked Incentive Scheme for IT Hardware
Cabinet has given approval for the Production Linked Incentive (PLI) Scheme for IT Hardware. The scheme proposes production linked incentive to boost domestic manufacturing and attract large investments in the value chain of IT Hardware. The Target Segments under the proposed Scheme include Laptops, Tablets, All-in-One PCs and Servers. This is an important segment to promote manufacturing under Atma Nirbhar Bharat as there is huge import reliance for these items at present. This scheme will enhance the development of electronics ecosystem in the country. India will be well positioned as a global hub for Electronics System Design and Manufacturing (ESDM) on account of integration with global value chains, thereby becoming a destination for IT Hardware exports. This scheme has an employment generation potential of over 1,80,000 (direct and indirect) over 4 years and will provide impetus to Domestic Value Addition for IT Hardware which is expected to rise to 20% - 25% by 2025.
https://pib.gov.in/PressReleseDetail.aspx?PRID=1700431
III. Cabinet approves Production Linked Incentive Scheme for Pharmaceuticals
Cabinet has given approval for the Production Linked Incentive (PLI) Scheme for Pharmaceuticals over a period of Financial Year 2020-21 to 2028-29. The scheme will be part of the umbrella scheme for the Development of Pharmaceutical Industry. The objective of the scheme is to enhance India's manufacturing capabilities by increasing investment and production in the sector and contributing to product diversification to high value goods in the pharmaceutical sector. The scheme is expected to promote the production of high value products in the country and increase the value addition in exports. It is expected to promote innovation for development of complex and high-tech products including products of emerging therapies and in-vitro Diagnostic Devices as also self-reliance in important drugs. It is also expected to improve accessibility and affordability of medical products including orphan drugs to the Indian population. The Scheme is also expected to bring in investment of Rs.15,000 crore in the pharmaceutical sector.
https://pib.gov.in/PressReleseDetail.aspx?PRID=1700433
